Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez Rivas M, et al. Anaphylaxis: guidelines from the European academy of allergy and clinical immunology. Allergy. 2014;69(8):1026–45.
Article
CAS
Google Scholar
Dhami S, Sheikh A, Muraro A, Roberts G, Halken S, Fernandez Rivas M, et al. Quality indicators for the acute and long-term management of anaphylaxis: a systematic review. Clin Transl Allergy. 2017;7:15.
Article
Google Scholar
Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmacol. 2003;3(7):909–20.
Article
CAS
Google Scholar
Ahmad SF, Zoheir KM, Ansari MA, Korashy HM, Bakheet SA, Ashour AE, et al. Stimulation of the histamine 4 receptor with 4-methylhistamine modulates the effects of chronic stress on the Th1/Th2 cytokine balance. Immunobiology. 2015;220(3):341–9.
Article
CAS
Google Scholar
Baumer W, Rossbach K. [Histamine as an immunomodulator]. J Dtsch Dermatol Ges. 2010;8(7):495–504.
PubMed
Google Scholar
Thurmond RL, Gelfand EW, Dunford PJ. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov. 2008;7(1):41–53.
Article
CAS
Google Scholar
Elenkov IJ, Webster E, Papanicolaou DA, Fleisher TA, Chrousos GP, Wilder RL. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors. J Immunol. 1998;161(5):2586–93.
CAS
PubMed
Google Scholar
Kupczyk M, Kuprys I, Bochenska-Marciniak M, Gorski P, Kuna P. Ranitidine (150mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc. 2007;28(6):711–5.
Article
CAS
Google Scholar
Runge JW, Martinez JC, Caravati EM, Williamson SG, Hartsell SC. Histamine antagonists in the treatment of acute allergic reactions. Ann Emerg Med. 1992;21(3):237–42.
Article
CAS
Google Scholar
Lin RY, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, et al. Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. Ann Emerg Med. 2000;36(5):462–8.
Article
CAS
Google Scholar
Dhanya NB, Rai R, Srinivas CR. Histamine 2 blocker potentiates the effects of histamine 1 blocker in suppressing histamine-induced wheal. Indian J Dermatol Venereol Leprol. 2008;74(5):475–7.
Article
CAS
Google Scholar
Arias K, Baig M, Colangelo M, Chu D, Walker T, Goncharova S, et al. Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions. J Allergy Clin Immunol. 2009;124(2):307–14. 14 e1-2.
Article
CAS
Google Scholar
Shah KM, Rank MA, Dave SA, Oslie CL, Butterfield JH. Predicting which medication classes interfere with allergy skin testing. Allergy Asthma Proc. 2010;31(6):477–82.
Article
Google Scholar
Fedorowicz Z, van Zuuren EJ, Hu N. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012;3:8596.
Google Scholar
Guevara-Gutierrez E, Bonilla-Lopez S, Hernandez-Arana S, Tlacuilo-Parra A. Safety and efficacy of cetirizine versus cetirizine plus ranitidine in chronic urticaria: Double-blind randomized placebo-controlled study. J Dermatolog Treat. 2015;26(6):548–50.
Article
Google Scholar
Hatakeyama M, Fukunaga A, Washio K, Ogura K, Yamada Y, Horikawa T, et al. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists. J Dermatol Sci. 2016;82(2):137–9.
Article
CAS
Google Scholar
Ogawa Y, Ichinokawa Y, Hiruma M, Machida Y, Funakushi N, Sadamasa H, et al. Retrospective cohort study on combination therapy with the histamine H2-receptor antagonist lafutidine for antihistamine-resistant chronic urticaria. J Dermatolog Treat. 2013;24(6):463–5.
Article
CAS
Google Scholar
Fukunaga A, Washio K, Hatakeyama M, Oda Y, Ogura K, Horikawa T, et al. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management. Clin Auton Res. 2018;28(1):103–13.
Article
Google Scholar
Zhang Y, Chen Z, Luo X, Wu B, Li B, Wang B. Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells. Hum Vaccin Immunother. 2016;12(10):2512–8.
Article
Google Scholar
Avella J, Madsen JE, Binder HJ, Askenase PW. Effect of histamine H2-receptor antagonists on delayed hypersensitivity. Lancet. 1978;1(8065):624–6.
Article
CAS
Google Scholar
Arae K, Oboki K, Ohno T, Hirata M, Nakae S, Taguchi H, et al. Cimetidine enhances antigen-specific IgE and Th2 cytokine production. Allergol Int. 2011;60(3):339–44.
Article
CAS
Google Scholar
Shin JH, Kim BG, Kim SW, Cho JH, Park YJ, Kim SW. Immunomodulatory role of histamine H2 receptor in allergen-specific immunotherapy: a mouse model of allergic rhinitis. Otolaryngol Head Neck Surg. 2011;144(4):500–5.
Article
Google Scholar
Ishikura H, Fukui H, Takeyama N, Tanaka T. Cimetidine activates interleukin-12, which enhances cellular immunity. Blood. 1999;93(5):1782–3.
Article
CAS
Google Scholar
Hahm KB, Kim WH, Lee SI, Kang JK, Park IS. Comparison of immunomodulative effects of the histamine-2 receptor antagonists cimetidine, ranitidine, and famotidine on peripheral blood mononuclear cells in gastric cancer patients. Scand J Gastroenterol. 1995;30(3):265–71.
Article
CAS
Google Scholar
Jafarzadeh A, Nemati M, Rezayati MT, Ebrahimi M, Hassan ZM. Cimetidine enhances delayed-type hypersensitivity responses and serum interleukin (IL)-2, -10, -12, and IL-17 levels after burn injury in an animal model. J Immunotoxicol. 2013;10(2):201–9.
Article
CAS
Google Scholar
Pastorello EA, Stafylaraki C, Mirone C, Preziosi D, Aversano MG, Mascheri A, et al. Anti-amoxicillin immunoglobulin E, Histamine-2 receptor antagonist therapy and mast cell activation syndrome are risk factors for amoxicillin anaphylaxis. Int Arch Allergy Immunol. 2015;166(4):280–6.
Article
CAS
Google Scholar
van der Pouw Kraan TC, Snijders A, Boeije LC, de Groot ER, Alewijnse AE, Leurs R, et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest. 1998;102(10):1866–73.
Article
Google Scholar
Novak N, Mete N, Bussmann C, Maintz L, Bieber T, Akdis M, et al. Early suppression of basophil activation during allergen-specific immunotherapy by histamine receptor 2. J Allergy Clin Immunol. 2012;130(5):1153–8 e2.
Article
CAS
Google Scholar
Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11(9):372–7.
Article
CAS
Google Scholar
Lee M, Lee NY, Chung KS, Cheon SY, Lee KT, An HJ. Roxatidine attenuates mast cell-mediated allergic inflammation via inhibition of NF-kappaB and p38 MAPK activation. Sci Rep. 2017;7:41721.
Article
CAS
Google Scholar
Geng B, Thakor A, Clayton E, Finkas L, Riedl MA. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015;115(1):33–8.
Article
CAS
Google Scholar
Simons FE, Sussman GL, Simons KJ. Effect of the H2-antagonist cimetidine on the pharmacokinetics and pharmacodynamics of the H1-antagonists hydroxyzine and cetirizine in patients with chronic urticaria. J Allergy Clin Immunol. 1995;95(3):685–93.
Article
CAS
Google Scholar